Skip to Main Content

ANNOUNCEMENT: Now Accepting Applications for our Fiscal Year 2024 Competitive Grant Program!

The OOCC is pleased to announce our Competitive Grant Program for fiscal year 2024. The purpose of the Competitive Grant Program is to distribute grant funding to the highest-scoring proposals received from state and local governments and community-based partners that serve to meet the greatest needs around the state. The funding available for the OOCC’s FY 24 Competitive Grants Program is approximately $6 million.

Who is Eligible

State agencies, local governments (including local school systems), and private or non-profit community-based partners are eligible to apply for Competitive Grant Program funding. All project proposals must address the opioid crisis through the policy priorities of Prevention & Education, Enforcement & Public Safety, and/or Treatment & Recovery. Additionally, projects must align with the goals established in the state’s Inter-Agency Opioid Coordination Plan.

How to Apply

The application deadline for FY 24 proposals is Wednesday, April 6, 2023, at 5 p.m. EDT. Interested parties should review the Call for Proposals. The document includes key dates, application process, evaluation standards, funding specifications, reporting requirements, and other information to complete the application process. Please contact Grants Program Coordinator Khalil Cutair at Khalil.Cutair@Maryland.gov or Grants Manager Deborah Davis at Deborahs.Davis1@maryland.gov with further questions. Note: For projects with a majority impact in Baltimore City, all requests for signature should be sent to Brittney Spencer, Director, Opioid Overdose Prevention, Baltimore City Health Department at Brittney.Spencer@baltimorecity.gov no later than March 16, 2023. A previous version of the Call for Proposals listed an incorrect date.

Relevant Materials

Key Dates

Access to Recovery Emergency Gap Funds Grant Program

The Opioid Operational Command Center’s new Access to Recovery Emergency Gap Funds Grant Program distributes funds to cover emergency expenses, such as transportation and extended stays in recovery programs. Organizations that work with individuals in recovery, such as recovery-focus community organizations, recovery residences that have been certified by the Behavioral Health Administration of the Maryland Department of Health, local health departments, and local behavioral health authorities will be eligible to receive funding through this program. The full list of Access to Recovery Emergency Gap Funds Grant Program awards in FY 2023 is available here.

Block Grant Program (Fiscal Year 2023)

The OOCC is distributing $4 million through its Block Grant Program, which ensures that all of Maryland’s 24 local jurisdictions receive a base level of funding to support overdose-related programs and initiatives. The program also takes into account local impacts of the opioid crisis and distributes half of the funds proportionally based on overdose mortality rates. These funds are distributed directly to local jurisdictions and will be administered by local health departments. The full list of FY 2023 block grant awards is available here.

Competitive Grant Program (Fiscal Year 2023)

The purpose of the OOCC’s Competitive Grant Program is to distribute grant funding to the highest-scoring proposals received from state and local governments and community-based partners that serve to meet the greatest needs around the state. The funding available for the OOCC’s FY 23 Competitive Grants Program is approximately $5 million. The full list of FY 2023 competitive grant awards is available here.

Examination and Treatment Act Grant Program

The OOCC will distribute $7.5 million in grant awards to support local jurisdictions with implementing the requirements of the Opioid Use Disorder Examination and Treatment Act (ETA) of 2019. This legislation requires that all local detention centers implement programs to screen incarcerated individuals for opioid use disorder, offer peer recovery specialist services and counseling services to develop re-entry plans for individuals upon release, and to offer all three FDA-approved formulations of medications for opioid use disorder, such as methadone or buprenorphine, in their facilities.

The grant awards will support projects in 16 local detention facilities, a summary of which can be found here.

Stay in Contact!

To receive notifications regarding future funding opportunities, please complete the following form to be added to our mailing list.

Mailing List Sign-Up Form

ae1a-ewspg-web3